Author

Long Jiang

Karolinska InstitutetORCID 0000-0002-8720-8992Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Long Jiang1 paper · University of Michigan

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Alejandro Fernandez-WoodbridgeiD· 1 shared Birce Akpinar· 1 shared Csaba KindleriD· 1 shared Fredrik WermelingiD· 1 shared Hans GrönlundiD· 1 shared Ingo Rimke· 1 shared Jerker WidengreniD· 1 shared Karen Schmidt· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alejandro Fernandez-WoodbridgeORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A neoantigen-microbead platform for personalized T cell cancer vaccination

Long Jiang, Birce Akpinar, Yue Li, Maryam Sanaee, Nathaniel A. Sanjaya, Karen Schmidt, Alejandro Fernandez-Woodbridge, Ola B. Nilsson, Luigi Notari, Csaba Kindler, Ingo Rimke, Olivia G. Thomas, Shigeaki Kanatani, Per Uhlén, Jerker Widengren, , Hans Grönlund

This study develops a neoantigen-microbead platform for personalized T cell cancer vaccination and shows it effectively inhibits tumor growth in a mouse model.

bioRxiv · Nov 21, 2025 · PreprintCancer Biology